Untitled Page
Main Menu
Home > Equity > News Analysis > Hot Pursuit
24 October 2021

Hot Pursuit

Prev Next
23-Oct-2021 (16:40)
ICICI Bank Q2 PAT rises 30% YoY to Rs 5,511 cr; NIM at 4%
23-Oct-2021 (15:43)
Tatva Chintan Pharma Q2 PAT soars 811% YoY to Rs 32 cr
On a sequential basis, the company posted a 40% rise in net profit on a 15.7% increase in revenue from operations to Rs 1,236.15 crore in Q2 FY22 over Q1 FY22. Profit before tax jumped nearly 46% quarter on quarter and 527% year on year to Rs 35.4 crore in Q2 FY22.

Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacturing of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). It is the largest and only commercial manufacturer of SDAs for zeolites in India.

Tatva Chintan closed 0.59% lower at Rs 2,132.05 on Friday.

Shares of Tatva Chintan Pharma Chem entered bourses on 29 July 2021. The scrip was listed at a price of Rs 2,111.80 per share, at a premium of 95% to the initial public offer (IPO) price of Rs 1,083. The IPO of specialty chemicals manufacturing company received bids for 58.83 crore shares as against 32.61 lakh shares on offer. The issue was subscribed 180.36 times. The issue opened for bidding on 16 July 2021 and closed on 20 July 2021. The price band of the IPO was fixed at Rs 1073-1083 per share...

23-Oct-2021 (14:00)
Metropolis Health completes acquisition of Hitech
23-Oct-2021 (13:21)
Zuari Agro Chemicals announces shutdown of NPK plants
23-Oct-2021 (13:00)
Grasim Industries acquires stake in wholly-owned arm, ABRSPL for Rs 1.30 lakh
23-Oct-2021 (12:20)
ABB Power Products and Systems India Q3 FY22 PAT grows 7-fold to Rs 34 cr
23-Oct-2021 (12:05)
Dow posts record closing high
23-Oct-2021 (12:03)
Dodla Dairy Q2 PAT slips 31% YoY to Rs 29 cr
23-Oct-2021 (11:09)
Sundaram-Clayton registers 34% YoY growth in Q2 PAT
23-Oct-2021 (11:07)
Tata Elxsi Q2 PAT rises 59% YoY to Rs 125 cr
Toll Free number: 1800-425-5501 / 1800-103-5501